Literature DB >> 14534512

Primary amebic meningoencephalitis--Georgia, 2002.

.   

Abstract

In early September 2002, the Georgia Division of Public Health and CDC were notified about a fatal case of primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri in a boy aged 11 years who had recently swum in a local river. This report summarizes the case investigation. In response to this case, the district health department recommended that local community authorities advise persons to avoid swimming in this river during periods of high temperature and low water depth.

Entities:  

Mesh:

Year:  2003        PMID: 14534512

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri.

Authors:  Yvonne Qvarnstrom; Govinda S Visvesvara; Rama Sriram; Alexandre J da Silva
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Fatal Naegleria fowleri meningoencephalitis, Italy.

Authors:  Paola E Cogo; Massimo Scagli; Simonetta Gatti; Flavio Rossetti; Rita Alaggio; Anna Maria Laverda; Ling Zhou; Lihua Xiao; Govinda S Visvesvara
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 4.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

Review 5.  Rapidly fatal infections.

Authors:  Diana Hans; Erin Kelly; Krista Wilhelmson; Eric D Katz
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.